Skip to main content
Clinical Trials/NCT04030494
NCT04030494
Completed
Not Applicable

Study of Validation of the Advanced Blood Pressure Monitor Withings WPM04 for the Detection of Anomalies of Arterial Pressure, Arrhythmia and Valvular Heart Diseases

Withings1 site in 1 country218 target enrollmentMarch 13, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Atrial Fibrillation
Sponsor
Withings
Enrollment
218
Locations
1
Primary Endpoint
AF and SR classification accuracy
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

The proposed clinical study aims to validate the effectiveness of the WPM04 blood pressure monitor developed by Withings as a diagnostic tool for cardiovascular disorders.

The detection of cardiovascular disorders is oriented along three axes, namely the measurement of blood pressure, the identification of rhythm disorders such as atrial fibrillation and the identification of heart murmur indicating valvular heart disease.

Registry
clinicaltrials.gov
Start Date
March 13, 2019
End Date
June 13, 2019
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Withings
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Male or female over 18 years old,
  • Subject who signed the consent form,
  • Subject affiliated to a social security scheme or entitled.

Exclusion Criteria

  • Underage subject;
  • Subject who refused to participate in the study;
  • Subject participating in other research or clinical studies;
  • Subject with body mass index greater than 35 kg/m2;
  • Subject in linguistic or psychic incapacity to sign an informed consent;
  • Subject with congenital cardiomyopathy;
  • Subject with aorto-venous fistula;
  • Subject with pulmonary pathology that may degrade the quality of the recording;
  • Subject presenting a serious pathology compromising the realization of the examinations envisaged in the test;
  • Subject with an arm injury incompatible with the use of an armband sphygmomanometer;

Outcomes

Primary Outcomes

AF and SR classification accuracy

Time Frame: 1 visit (30 minutes)

sensitivity and specificity of detection of AF and SR from 1-lead ECG against 12-lead ECG

VHD detection accuracy

Time Frame: 1 visit (30 minutes)

sensitivity and specificity of detection of VHD from phonocardiogram against Doppler echocardiogram

BP precision and accuracy

Time Frame: 1 visit (45 minutes)

mean error and standard deviation on measurements, and standard deviation on patients (criteria 1 and 2 of ANSI/AAMI/ISO 81060-2:2013) against sphygmomanometer dual observer auscultation

Secondary Outcomes

  • safety evaluation(1 visit (1 hour))

Study Sites (1)

Loading locations...

Similar Trials